ICU sedation, delirium & recovery

Variation in Use of Medications for Opioid Use Disorder in Critically Ill Patients Across the United States

Crit Care MedPublished Retrospective cohort study

Authors' conclusion

In a large multicenter, retrospective study, there was large variation in the use of MOUD among ICU patients with a history of OUD.

Study context

Population
Adults (≥ 18 yr) with a history of opioid use disorder (OUD) admitted to US ICUs, 2016–2020
Participants
108,189 adults · 658 hospitals
Outcome
Received MOUD
Methodological detailsmulticentre, observational, Premier AI Healthcare Database
  • Multicentre
  • Observational
  • Premier AI Healthcare Database

Main finding

As reported in the abstract

Received MOUD
20,508 (19.0%)
Methadone, among MOUD recipients
13,745 (67.0%)
Buprenorphine, among MOUD recipients
2,950 (14.4%)
Buprenorphine/naloxone, among MOUD recipients
4,227 (20.6%)
MOUD use per hospital, median (IQR; range)
16.0% (10-24; 0-70.0%)
Variation in MOUD use explained by admitting hospital
8.9%

Observational data: associations, not effects.

Further findings

Factors associated with receiving MOUD in the ICU

aOR (95% CI)
Primary admitting diagnosis of unintentional poisoning0.41 (0.38–0.45)
Additional substance use disorder0.66 (0.64–0.68)

MOUD use among patients on invasive mechanical ventilation

MOUD use
37.9%

MOUD initiation and duration

Median day of MOUD initiation, hospital day (IQR)
2 (1-3)
Median duration of MOUD use, days (IQR)
4 (2-8)

Factors associated with receiving MOUD in the ICU

Factors indicating greater severity of illness associated with reduced odds of receiving MOUD

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Variation in Use of Medications for Opioid Use Disorder in Critically Ill Patients Across the United States. Crit Care Med. Published 19 March 2024. doi:10.1097/ccm.0000000000006257

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.